Ted Skolarus to Androgen Antagonists
This is a "connection" page, showing publications Ted Skolarus has written about Androgen Antagonists.
Connection Strength
3.213
-
De-implementation of low value castration for men with prostate cancer: protocol for a theory-based, mixed methods approach to minimizing low value androgen deprivation therapy (DeADT). Implement Sci. 2018 11 29; 13(1):144.
Score: 0.595
-
The implications of baseline bone-health assessment at initiation of androgen-deprivation therapy for prostate cancer. BJU Int. 2018 04; 121(4):558-564.
Score: 0.555
-
Androgen-deprivation-associated bone disease. Curr Opin Urol. 2014 Nov; 24(6):601-7.
Score: 0.449
-
Editorial comment. Urology. 2013 Apr; 81(4):751.
Score: 0.402
-
Hormonal Therapy and Radiation Therapy in Prostate Cancer: 5-Year Outcomes From a Trial Evaluating Combined Androgen Blockade With 5-Alpha Reductase Inhibitors as an Alternative to Gonadotropin Releasing Hormone Agonists. Clin Genitourin Cancer. 2024 Aug; 22(4):102103.
Score: 0.216
-
Outcomes after definitive radiation therapy for localized prostate cancer in a national health care delivery system. Cancer. 2023 10 15; 129(20):3326-3333.
Score: 0.204
-
Better Understanding the Timing Of Androgen Deprivation Trial Outcomes: Impacts of Prior Androgen Deprivation Therapy. JNCI Cancer Spectr. 2022 05 02; 6(3).
Score: 0.189
-
TrueNTH Sexual Recovery Intervention for couples coping with prostate cancer: Randomized controlled trial results. Cancer. 2022 Apr 01; 128(7):1513-1522.
Score: 0.185
-
Factors influencing treatment of veterans with advanced prostate cancer. Cancer. 2021 07 01; 127(13):2311-2318.
Score: 0.175
-
Characterising potential bone scan overuse amongst men treated with radical prostatectomy. BJU Int. 2019 07; 124(1):55-61.
Score: 0.148
-
Mapping European Association of Urology Guideline Practice Across Europe: An Audit of Androgen Deprivation Therapy Use Before Prostate Cancer Surgery in 6598 Cases in 187 Hospitals Across 31 European Countries. Eur Urol. 2023 05; 83(5):393-401.
Score: 0.049
-
Improving Guideline Adherence in Urology. Eur Urol Focus. 2022 09; 8(5):1545-1552.
Score: 0.045